Literature DB >> 28912161

Disruption of Bmal1 Impairs Blood-Brain Barrier Integrity via Pericyte Dysfunction.

Ryota Nakazato1, Kenji Kawabe2, Daisuke Yamada2, Shinsuke Ikeno1, Michihiro Mieda3, Shigeki Shimba4, Eiichi Hinoi1, Yukio Yoneda1, Takeshi Takarada5,2.   

Abstract

Circadian rhythm disturbances are well established in neurological diseases. However, how these disruptions cause homeostatic imbalances remains poorly understood. Brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein 1 (Bmal1) is a major circadian clock transcriptional activator, and Bmal1 deficiency in male Bmal1nestin-/- mice induced marked astroglial activation without affecting the number of astrocytes in the brain and spinal cord. Bmal1 deletion caused blood-brain barrier (BBB) hyperpermeability with an age-dependent loss of pericyte coverage of blood vessels in the brain. Using Nestin-green fluorescent protein (GFP) transgenic mice, we determined that pericytes are Nestin-GFP+ in the adult brain. Bmal1 deletion caused Nestin-GFP+ pericyte dysfunction, including the downregulation of platelet-derived growth factor receptor β (PDGFRβ), a protein necessary for maintaining BBB integrity. Knockdown of Bmal1 downregulated PDGFRβ transcription in the brain pericyte cell line. Thus, the circadian clock component Bmal1 maintains BBB integrity via regulating pericytes.SIGNIFICANCE STATEMENT Circadian rhythm disturbances may play a role in neurodegenerative disorders, such as Alzheimer's disease. Our results revealed that one of the circadian clock components maintains the integrity of the blood-brain barrier (BBB) by regulating vascular-embedded pericytes. These cells were recently identified as a vital component for the control of BBB permeability and cerebral blood flow. Our present study demonstrates the involvement of circadian clock component Bmal1 in BBB homeostasis and highlights the role of Bmal1 dysfunction in multiple neurological diseases.
Copyright © 2017 the authors 0270-6474/17/3710052-11$15.00/0.

Entities:  

Keywords:  Clock gene; blood–brain barrier; pericyte

Mesh:

Substances:

Year:  2017        PMID: 28912161      PMCID: PMC6596539          DOI: 10.1523/JNEUROSCI.3639-16.2017

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  31 in total

Review 1.  Association between circadian rhythms and neurodegenerative diseases.

Authors:  Yue Leng; Erik S Musiek; Kun Hu; Francesco P Cappuccio; Kristine Yaffe
Journal:  Lancet Neurol       Date:  2019-02-12       Impact factor: 44.182

2.  Hippocampal neural stem cells facilitate access from circulation via apical cytoplasmic processes.

Authors:  Esther Sasson; Batia Bell; Tamar Licht; Myriam Grunewald; Saran Kumar; Tirzah Kreisel; Ayal Ben-Zvi; Eli Keshet
Journal:  Elife       Date:  2020-06-04       Impact factor: 8.140

Review 3.  Training the Circadian Clock, Clocking the Drugs, and Drugging the Clock to Prevent, Manage, and Treat Chronic Diseases.

Authors:  Gabriele Sulli; Emily N C Manoogian; Pam R Taub; Satchidananda Panda
Journal:  Trends Pharmacol Sci       Date:  2018-07-27       Impact factor: 14.819

Review 4.  Circadian regulation of astrocyte function: implications for Alzheimer's disease.

Authors:  Celia A McKee; Brian V Lananna; Erik S Musiek
Journal:  Cell Mol Life Sci       Date:  2019-09-27       Impact factor: 9.261

Review 5.  Timing in drug absorption and disposition: The past, present, and future of chronopharmacokinetics.

Authors:  Joana Bicker; Gilberto Alves; Amílcar Falcão; Ana Fortuna
Journal:  Br J Pharmacol       Date:  2020-03-20       Impact factor: 8.739

Review 6.  Potential Circadian Rhythms in Oligodendrocytes? Working Together Through Time.

Authors:  Christopher S Colwell; Cristina A Ghiani
Journal:  Neurochem Res       Date:  2019-03-25       Impact factor: 3.996

7.  Cell-Autonomous Regulation of Astrocyte Activation by the Circadian Clock Protein BMAL1.

Authors:  Brian V Lananna; Collin J Nadarajah; Mariko Izumo; Michelle R Cedeño; David D Xiong; Julie Dimitry; Chak Foon Tso; Celia A McKee; Percy Griffin; Patrick W Sheehan; Jeffery A Haspel; Ben A Barres; Shane A Liddelow; Joseph S Takahashi; Ilia N Karatsoreos; Erik S Musiek
Journal:  Cell Rep       Date:  2018-10-02       Impact factor: 9.423

Review 8.  Transgenic models for investigating the nervous system: Currently available neurofluorescent reporters and potential neuronal markers.

Authors:  Michael Yamakawa; Samuel M Santosa; Neeraj Chawla; Evguenia Ivakhnitskaia; Matthew Del Pino; Sebastian Giakas; Arnold Nadel; Sneha Bontu; Arjun Tambe; Kai Guo; Kyu-Yeon Han; Maria Soledad Cortina; Charles Yu; Mark I Rosenblatt; Jin-Hong Chang; Dimitri T Azar
Journal:  Biochim Biophys Acta Gen Subj       Date:  2020-03-12       Impact factor: 3.770

Review 9.  Blood-brain barrier dysfunction as a potential therapeutic target for neurodegenerative disorders.

Authors:  Ajay Uprety; Yeji Kang; Soo Young Kim
Journal:  Arch Pharm Res       Date:  2021-05-24       Impact factor: 4.946

10.  A subtype of cerebrovascular pericytes is associated with blood-brain barrier disruption that develops during normal aging and simian immunodeficiency virus infection.

Authors:  Diana G Bohannon; Hamid R Okhravi; Jayoung Kim; Marcelo J Kuroda; Elizabeth S Didier; Woong-Ki Kim
Journal:  Neurobiol Aging       Date:  2020-08-17       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.